(Q34031521)

English

Retracted: Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells

retracted article

Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

retracted paper

0 references

Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Retracted: Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells (English)

0 references

object named as

Michal Marzec

1

0 references

Mariusz A Wasik

6

object named as

Mariusz A Wasik

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Xiaobin Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Maria Wysocka

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alain H Rook

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Niels Odum

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

16 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

e24849

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution 4.0 International

16 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Temsirolimus in mantle cell lymphoma and other non-Hodgkin lymphoma subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Novel translational control in Arc-dependent long term potentiation consolidation in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Mycosis fungoides and Sézary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174990

28 July 2018

The mTOR pathway: a new target in cancer therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

MNK, EIF4E and targeting translation for therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024849

21 January 2018

Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1371/JOURNAL.PONE.0024849

Re: eIF4E Phosphorylation Promotes Tumorigenesis and is Associated With Prostate Cancer Progression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1371/JOURNAL.PONE.0024849

Identifiers

10.1371/JOURNAL.PONE.0024849

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2011PLoSO...624849M

0 references

release_hhjirw6jpveybjgqwuoelcljr4

1 reference

https://api.fatcat.wiki/v0/release/hhjirw6jpveybjgqwuoelcljr4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34031521&oldid=2073077178"